NCM
PFE icon

Northstar Capital Management’s Pfizer PFE Stock Holding History

Northstar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,660
Closed -$56K – 91
2018
Q1 		$56K Hold
1,660
– – 0.05% 61
2017
Q4 		$57K Buy
+1,660
New +$56.6K 0.05% 64

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northstar Capital Management's PFE Position: Q2 2018 in Review

Northstar Capital Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 1,660 shares — an estimated $56K sold.

Northstar Capital Management first reported a position in PFE in Q4 2017 and held it in 2 quarters. The position peaked at $57K in Q4 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Northstar Capital Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Northstar Capital Management sold 1,660 Pfizer shares in Q2 2018, an estimated $56K.
  • Northstar Capital Management first reported a position in Pfizer in Q4 2017 and held it in 2 quarters.
  • Northstar Capital Management's Pfizer position peaked at $57K in Q4 2017.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Northstar Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.